Literature DB >> 6759499

Comparison of buspirone in two separate studies.

H L Goldberg, R Finnerty.   

Abstract

Two double-blind studies are described in which buspirone was compared with placebo and diazepam (Study A) or clorazepate (Study B) in outpatients with moderate to severe anxiety. Results, assessed on the Hamilton Rating Scales for Depression and Anxiety, the SCL-56, the Profile of Mood States, and the Covi and Raskin scales, indicated that buspirone consistently relieved both anxiety and associated depression. In Study B, trends in favor of buspirone were seen on several SCL-56 items and the Hamilton somatic factor; significant differences in this direction were found for several POMS items. Sedation was seen less often with buspirone than either diazepam or clorazepate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759499

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

Review 1.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.

Authors:  P P De Deyn; R L Macdonald
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

3.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  Anticonflict effects of buspirone and chlordiazepoxide in pigeons under a concurrent schedule with punishment and a changeover response.

Authors:  F H Wojnicki; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade.

Authors:  G Engberg
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Buspirone: an anxiolytic without sedative effect.

Authors:  W F Seidel; S A Cohen; N G Bliwise; W C Dement
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.

Authors:  R Enkelmann
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats.

Authors:  Kyoko Nishi; Kazuya Kanemaru; Shu Hasegawa; Arata Watanabe; Mirko Diksic
Journal:  Neurochem Int       Date:  2008-11-25       Impact factor: 3.921

Review 9.  Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.

Authors:  J R Steinberg
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

Review 10.  Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.

Authors:  K L Goa; A Ward
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.